Sinus & Nasal Issues Questions

Allergic rhinitis is an immune response to allergens — pollen, dust mites, pet dander, mould — causing sneezing, watery nasal discharge, nasal congestion, and itchy eyes. It is not an infection. Sinusitis is inflammation of the sinus cavities — usually from a viral or bacterial infection but sometimes from allergy or structural problems — causing thick coloured discharge, facial pain and pressure, reduced smell, and congestion. They frequently overlap: poorly controlled allergic rhinitis inflames the sinus openings and predisposes to sinusitis. Treatment differs: allergic rhinitis is managed with antihistamines, intranasal corticosteroid sprays, and allergen avoidance; acute bacterial sinusitis may need antibiotics (though most acute sinusitis is viral). Nasal corticosteroid sprays benefit both conditions.

Nasal corticosteroid sprays (fluticasone, mometasone, budesonide) are the most effective treatment for allergic rhinitis and chronic sinusitis — but they are widely used incorrectly, reducing effectiveness. Correct technique: blow your nose first. Shake the bottle. Tilt your head slightly forward (not back — that causes the medication to run down the throat). Direct the spray toward the outer wall of the nostril (away from the nasal septum) — pointing toward the ear on that side. Breathe in gently through the nose as you spray. Don't sniff hard. Breathe out through the mouth. Repeat in the other nostril directing toward its outer wall. These sprays take 1-2 weeks of consistent use to reach full effect — don't judge them after one dose. They are safe for long-term use at prescribed doses.

Nasal polyps are soft, non-cancerous growths that develop from inflamed nasal or sinus lining — they look like small grapes and cluster near the sinus openings. They cause persistent congestion, significantly reduced or absent sense of smell, post-nasal drip, and recurrent sinusitis. They are strongly associated with allergic rhinitis, asthma, and aspirin sensitivity. Treatment starts with high-dose nasal corticosteroid sprays and, in more severe cases, short courses of oral steroids — these shrink polyps effectively. Newer biologic treatments (dupilumab) are highly effective for severe polyps with asthma. Surgery (FESS — functional endoscopic sinus surgery) removes polyps when medical treatment fails, but polyps recur in 40-60% of patients without ongoing medical treatment. Surgery and medical treatment work best together.

A deviated septum — where the wall between the nostrils bends to one side — is present in the majority of people to some degree. Most cause no problems at all. Surgery (septoplasty) is indicated only when the deviation is causing significant symptoms that don't respond to medical treatment: persistent nasal obstruction on one side, recurrent sinusitis due to blocked drainage, sleep disruption from severe obstruction, or nosebleeds from exposed dry mucosa on the deviation. It is not cosmetic surgery (that's rhinoplasty) unless the external shape of the nose is also being altered. Recovery is 1-2 weeks. Results are good for obstruction but surgery doesn't 'cure' allergies — if allergic rhinitis is the main driver, medical treatment matters more.

Yes — loss of smell (anosmia) or reduced smell (hyposmia) is one of the most distressing symptoms of chronic sinusitis and nasal polyps. It happens because swelling and polyps physically block the olfactory cleft (where smell receptors are located) and because chronic inflammation damages the receptor cells. With effective treatment — nasal steroids, systemic steroids when needed, and surgical clearance if polyps are large — smell often returns partially or fully, though recovery can take months. Post-COVID anosmia is a distinct mechanism (direct nerve damage) and recovers differently. Smell training — deliberately sniffing four different essential oils twice daily for months — has the best evidence for post-viral smell loss and is increasingly recommended for post-sinusitis smell recovery too.

Caregivers are often the first to notice that something is wrong, since elderly patients — particularly those with cognitive impairment — may not report throat pain or discomfort. Watch for: sudden change in appetite or refusal to eat or drink, increased irritability or restlessness, unexplained low-grade fever (even 37.5°C matters in an elderly person whose baseline is lower), drooling or difficulty swallowing, visible redness at the back of the throat when asking them to open their mouth, or a sudden worsening of confusion in someone with dementia. Do not assume it is 'just a cold' — take the person to a GP or urgent care for a throat swab. If strep is confirmed, ensure the full antibiotic course is completed even when the patient appears to have recovered, because stopping early is the main driver of complications like rheumatic fever. In nursing home settings, report the case to the infection control lead — strep outbreaks in residential care require contact tracing and sometimes prophylactic antibiotics for close contacts.

Strep spreads through respiratory droplets and contact with contaminated surfaces, making communal living environments like nursing homes and assisted living facilities high-risk settings. Prevention requires a layered approach: (1) Hand hygiene — staff and residents should wash hands with soap and water for at least 20 seconds before meals, after toileting and after contact with any unwell resident; alcohol-based hand rub is second-best for strep (soap is more effective); (2) Respiratory etiquette — any resident or staff with a sore throat or upper respiratory symptoms should wear a surgical mask and, if confirmed strep-positive, be isolated from communal dining and activities until they have been on antibiotics for at least 24 hours and are fever-free; (3) Surface cleaning — door handles, handrails, communal dining tables and bathroom fixtures should be disinfected daily; (4) Staff sick-leave policy — staff with sore throat should be tested before returning to work in a care environment; (5) Outbreak response — if two or more residents develop strep within a short period, notify the local health authority and consider testing all close contacts; some guidelines recommend prophylactic penicillin for high-risk contacts during outbreaks in residential care.

Basic oral hygiene, prompt treatment of mouth wounds and fly-proofing the sleeping environment prevent most cases. Brush twice daily, floss, and get regular dental check-ups so ulcers, cavities and gum disease are treated early. Anyone with a wound in the mouth (after tooth extraction, oral surgery or injury) should follow post-op instructions carefully and finish the prescribed antibiotics. Caregivers of bedridden, disabled or elderly people should provide daily mouth care — cleaning teeth, swabbing the gums and keeping the lips closed during sleep. In areas with heavy fly populations, use mosquito nets, keep windows screened and dispose of waste properly. Managing alcohol use, controlling diabetes and treating oral cancers early are also part of long-term prevention. Any suspicion of larvae in the mouth needs same-day dental review.

Treatment is urgent — dentists or oral surgeons remove the larvae manually and clean the wound, then treat any underlying cause. Live larvae are picked out one by one using forceps under direct vision after topical anaesthesia. In some cases doctors apply substances like turpentine oil, ether or chloroform to bring hidden larvae to the surface, then remove them. Ivermectin, an antiparasitic drug, is often given orally to kill any remaining larvae. After removal the wound is thoroughly irrigated with antiseptic (hydrogen peroxide or povidone-iodine), and antibiotics are prescribed to prevent secondary bacterial infection. Necrotic tissue is surgically debrided. Underlying conditions — untreated caries, oral cancer, uncontrolled diabetes, dental abscesses — must be addressed to prevent recurrence. Follow-up over the next 1–2 weeks confirms full clearance.

It's rare overall, but people with poor oral hygiene, alcohol use disorder, uncontrolled diabetes, mental or physical disability, or oral cancer are at highest risk. Anyone who cannot maintain their own oral hygiene — bedridden elderly patients, people with severe neurological disability, unconscious patients — is at particular risk. Heavy alcohol use plays a big role: alcohol both reduces oral hygiene and can leave a person unconscious with the mouth open. Living in tropical or subtropical areas with a high fly population increases exposure, and outdoor sleeping without any face cover raises the risk further. Immunocompromised people (HIV, chemotherapy, diabetes) heal slowly, so any oral wound stays open longer. Children with cleft lip and palate that are not surgically closed have also been reported cases in medical literature.

Strep throat (caused by Group A Streptococcus) typically comes on suddenly — severe sore throat, painful swallowing, fever usually over 101°F, tonsils swollen with white or yellow patches or pus, tender lymph nodes in the front of the neck, and characteristically the absence of cough, runny nose, or hoarseness. Small red spots on the soft palate are sometimes visible. Viral sore throat (the most common cause, 70-85% of cases) is gradual, milder, comes with cough, runny nose, red eyes and hoarseness, and shows diffuse throat redness without pus. Doctors use the Centor criteria — fever, absence of cough, tender anterior neck lymph nodes, tonsillar exudate — with 3-4 features suggesting bacterial infection and warranting a test. Age matters: strep is more common in children 5-15 and less common in adults. Diagnosis uses a Rapid Antigen Detection Test (result in 10 minutes) or throat culture (gold standard, 24-48 hours). Every confirmed strep should be treated — to prevent rheumatic fever complications.

First-line treatment is Penicillin V (Phenoxymethylpenicillin) 500 mg orally 2-3 times daily for 10 days (children: 250 mg twice daily) — cheap and highly effective. Amoxicillin at 500 mg three times daily for 10 days is an alternative (often preferred for children because it tastes better). For penicillin allergy, use Cephalexin, Azithromycin (5 days), or Clarithromycin. In severe cases or when adherence is a concern, a single intramuscular Benzathine Penicillin G injection is an option — also used for rheumatic fever secondary prophylaxis. Complete the full 10 days even after feeling better — incomplete courses allow bacteria to survive and dramatically increase rheumatic fever risk (which can permanently damage heart valves). Supportive care: warm salt-water gargles, paracetamol or ibuprofen for fever and pain, adequate fluids and rest, soft cold foods, and avoid smoking. You're no longer contagious 24 hours after starting antibiotics. Household spread is common (25-40% of contacts) — test any symptomatic family members. If you have more than 3 episodes a year, consider ENT evaluation for tonsillectomy.

Flies lay eggs on open wounds, ulcers or areas of dead tissue in the mouth — the eggs hatch into larvae within a day or two. Certain blowflies (Chrysomya, Cochliomyia, Sarcophaga species) are attracted to the smell of blood, pus or decaying tissue. If a person has an unhealed dental extraction wound, an untreated ulcer, a mouth cancer, gum disease, or lives in an environment with heavy fly exposure, the flies can land and deposit eggs while the mouth is open — most often during sleep. The larvae hatch, burrow into soft tissue and feed. This is why oral myiasis is so strongly linked with sleeping with the mouth open, mouth breathing during sleep, alcohol intoxication, and disability that prevents the person from keeping the mouth clean or closed.

Untreated or under-treated strep can cause serious complications. Rheumatic fever, 1-3 weeks after infection, is an immune reaction affecting joints, heart, brain and skin; it causes rheumatic heart disease — still the leading cause of acquired heart disease in Indian children (with prevalence around 1-5 per 1000 school children) — and permanently damages heart valves. It's entirely preventable with a timely 10-day antibiotic course. Post-streptococcal glomerulonephritis affects the kidneys 1-3 weeks after infection with inflammation, blood in urine, and high blood pressure. Peritonsillar abscess (quinsy) is a pus collection behind the tonsil, with severe pain, drooling, muffled voice and inability to open the mouth fully — needs urgent ENT drainage. Scarlet fever presents with a sandpaper rash and strawberry tongue. Deep neck-space abscesses are medical emergencies. In children, rare neuropsychiatric syndromes (PANDAS/PANS) can follow strep. The India-specific concern is the ongoing rheumatic heart disease burden — every child with possible strep throat should be tested and treated properly.

Strep throat in older adults often looks nothing like the textbook case. Classic strep in younger people — sudden severe sore throat, high fever, bright red tonsils with white patches — may be absent or muted in seniors. Instead, an elderly person with strep may have only mild throat discomfort, low-grade or no fever (because the aging immune system mounts a weaker febrile response), unexplained fatigue, loss of appetite, confusion or mild delirium (especially in those over 80 or with dementia), or gastrointestinal symptoms like nausea. This atypical presentation means strep throat is frequently missed or attributed to a cold or 'just tiredness' in seniors. Any unexplained throat discomfort or sudden decline in an elderly person — especially with known exposure to someone with strep — warrants a rapid antigen detection test (RADT) or throat swab rather than a wait-and-see approach.

Four daily/weekly practices extend hearing aid life: (1) wipe with a dry cloth after removal — no water, no alcohol; (2) open the battery compartment when not in use overnight to dry out moisture; (3) use a dehumidifier box (₹500–2,000, one-time cost) especially in humid Indian coastal cities; (4) get a professional cleaning and tuning every 6 months at your audiology centre. Well-maintained digital hearing aids last 5–7 years; premium models can last 8–10.

Growing evidence suggests yes. Untreated hearing loss is one of the strongest modifiable risk factors for dementia — the Lancet Commission on Dementia Prevention lists it among the top 12 modifiable factors, accounting for roughly 8% of population-attributable risk. The mechanism: brain regions that process sound stay engaged; social isolation from hearing loss (a separate risk factor) is reduced. The ACHIEVE trial (2023) showed a 48% cognitive-decline reduction in at-risk older adults with 3 years of hearing aid use versus health education alone.

Basic analog BTE hearing aids start at ₹5,000–15,000 per ear. Mid-range digital hearing aids with directional microphones and noise reduction range ₹25,000–75,000 per ear. Premium models with Bluetooth, rechargeable batteries, and AI noise cancellation cost ₹75,000–2,50,000+ per ear. Health insurance in India typically doesn't cover hearing aids. Some brands (Signia, Phonak, ReSound, Widex) offer EMI options through audiology centres.

For most elderly first-time users, Behind-the-Ear (BTE) is the recommended starter — it's durable, easy to handle (large buttons, visible), works for all severity levels, and has fewer maintenance issues than smaller in-ear models. In-the-Ear (ITE) suits those wanting a less-visible option with mild-to-severe loss. Completely-in-the-Canal (CIC) is the most discreet but requires better dexterity for cleaning and battery changes — often difficult for elderly with arthritis or vision loss.

Elderly patients face a higher risk of strep throat complications for two reasons: delayed diagnosis (because atypical presentation means treatment starts later) and comorbidities that compound the infection. The most serious complication is rheumatic fever — an inflammatory reaction that can damage heart valves (rheumatic heart disease) if strep is untreated or undertreated. While rheumatic fever is less common in adults than in children, older adults with pre-existing cardiovascular disease, diabetes, or immunosuppression are at greater risk of severe outcomes. Other complications include peritonsillar abscess (pus collection behind the tonsil), otitis media (ear infection), sinusitis, and — in rare cases — septicaemia from untreated bacteraemia. Seniors in communal settings like nursing homes face additional exposure risk since group A streptococcus spreads quickly through shared air and surfaces. A full 10-day course of antibiotics (penicillin or amoxicillin) is essential to prevent post-streptococcal complications even when the patient feels better within a few days.

Treat colds and sinus infections early (they spread to ears via the eustachian tube), avoid smoking and second-hand smoke, keep vaccinations current (especially pneumococcal), and dry ears thoroughly after swimming. For chronic recurrent cases, an ENT may recommend tympanostomy tubes to improve middle-ear drainage.

Conductive is a blockage or damage in the outer/middle ear stopping sound from reaching the inner ear — usually treatable. Sensorineural is damage to the inner ear or hearing nerve — usually permanent. You can have both together (mixed). An audiologist's air-bone gap test on audiometry distinguishes them.

Often yes. Wax removal restores hearing immediately. Ear infections resolve with antibiotics + drainage. Perforated eardrums can heal on their own or with surgery (tympanoplasty). Otosclerosis responds well to stapedectomy surgery. Congenital malformations may need reconstructive surgery — outcomes vary.

Pure-tone audiometry (with air and bone conduction to identify the air-bone gap), tympanometry (measures eardrum movement), and otoscopy (visual inspection). CT scan of temporal bone is added if surgery is being considered. Full ENT workup usually ₹1,500–3,500 in India.

Any sudden hearing loss (medical emergency, within 72 hours), persistent ear pain more than 48 hours, ear discharge, hearing loss with dizziness or facial weakness, and any hearing change lasting more than 2 weeks. For gradual hearing decline in elderly, first appointment can be with an audiologist directly.

Moderate hearing loss (41–55 dB) and above typically benefits from a hearing aid. Mild loss (26–40 dB) is often manageable with lifestyle adjustments but hearing aids help in noisy settings or professional contexts. Severe (56–70 dB) and profound (>70 dB) loss almost always require amplification for daily function.

Pure-tone audiometry produces an audiogram — a chart showing hearing threshold in decibels (dB) at different frequencies. Normal is 0–25 dB. The severity level is based on the average threshold across speech frequencies (500 Hz, 1 kHz, 2 kHz, 4 kHz) in the better ear. Test takes 20–30 minutes; painless.

No — the opposite, actually. Early hearing aid use protects cognitive function (untreated hearing loss increases dementia risk 2–5x), preserves social engagement, and gives your brain time to adjust to amplified sound. Waiting doesn't 'save' hearing; it accelerates functional decline.

Analog amplifies all sounds equally. Digital uses a signal processor to filter noise, boost speech frequencies, and adjust based on environment (quiet room vs restaurant). Digital sounds more natural and adapts automatically. Analog is cheaper (₹3,000–8,000) but nearly obsolete — most Indian audiologists now recommend digital-only.

Common signs: family complains you turn TV volume up, you ask people to repeat frequently, difficulty following group conversations, avoiding social gatherings, or persistent ringing (tinnitus). If 2+ apply and have lasted 3+ months, get an audiogram — not a self-test online.

Basic digital: ₹15,000–₹40,000 per ear. Mid-range with directional mics and Bluetooth: ₹40,000–₹1,00,000. Premium with AI noise reduction, rechargeable, smartphone control: ₹1,00,000–₹2,50,000+. ALIMCO (government) offers subsidised digital aids for eligible seniors. Check for aid programs at state levels too.

Behind-the-ear (BTE) is easiest for elderly to handle — larger controls, easier to insert, longer battery life. In-the-ear (ITE) is more discreet but smaller controls. Invisible-in-canal (IIC) needs younger hands with good dexterity. If your parent has arthritis or memory issues, BTE almost always wins on usability.

Yes for tech-comfortable users — you can stream phone calls, music, TV audio directly to the aids without external speakers. Reduces background listening effort significantly. If your parent isn't smartphone-literate, Bluetooth adds cost without benefit — pick a non-Bluetooth model and save money.

Sometimes. Conductive hearing loss (from earwax, infection, or fluid buildup) is often reversible with treatment. Sensorineural hearing loss (from inner-ear or nerve damage) is usually permanent — but hearing aids or cochlear implants can restore function. Sudden hearing loss is a medical emergency needing treatment within 72 hours.

There's a strong correlation. A Johns Hopkins study found people with untreated moderate hearing loss have up to 3–5x higher dementia risk. The 2020 Lancet Commission ranks hearing loss as the #1 modifiable dementia risk factor. Hearing aids reduce that risk — early treatment matters.

Baseline test at 60, then every 2–3 years, or immediately if there are signs: turning TV volume up, asking people to repeat, difficulty in group conversations, or tinnitus. India has audiologist consultations for ₹500–1500 and free hearing camps through ALIMCO and speech-hearing colleges.

Start with audiologist assessment (₹500–1500). Basic analog aids cost ₹5,000–15,000; digital aids ₹15,000–1,50,000+ depending on features. ALIMCO (government) provides subsidised aids for eligible seniors. Give the aid 2–3 weeks of consistent use — brains take time to adjust to amplified sound.

Yes, under the Rights of Persons with Disabilities Act 2016. Hearing loss above 40 dB in the better ear qualifies as 'hearing impairment' — a benchmark disability. This entitles the person to disability certificates, reservations, tax benefits, and workplace accommodations.

Get an audiologist test (pure-tone audiometry) at a government hospital or empanelled centre. Apply through the district Chief Medical Officer office or state disability portal. Certificate is issued in Universal Disability ID (UDID) format online. Cost is free at government facilities. Renewal every 3–5 years for progressive cases.

Under RPWD Act — assistive listening devices, captioning services in meetings, written follow-ups after verbal instructions, quiet workspace, seating with clear sightlines, and reasonable rest breaks. Employers with 20+ staff have a legal duty to provide reasonable accommodations at no cost to the employee.

Income tax deduction under Section 80U (₹75,000–₹1.25 lakh depending on severity), subsidised hearing aids through ALIMCO, priority in government job reservations (1% under 'hearing impaired' quota), disability pension in some states, and travel concessions on Indian Railways.

Usually no — most ear infections cause temporary hearing loss that resolves within days to weeks. But recurring or chronic infections (especially chronic suppurative otitis media, common in India) can damage the eardrum or middle-ear bones over time, leading to permanent conductive hearing loss. Prompt treatment prevents this.

Ear pain, feeling of fullness, muffled hearing on the affected side, sometimes fever, discharge from the ear (yellow or foul-smelling means bacterial), and hearing sensitivity to loud sounds. In young children — irritability, tugging at the ear, sleep problems. See a doctor if symptoms last more than 48 hours.

No. Viral ear infections resolve on their own; antibiotics don't help. Bacterial infections may need antibiotics — usually amoxicillin as first-line. Doctors often 'watch and wait' 48–72 hours for mild cases in adults and older children, prescribing antibiotics only if symptoms worsen or persist.

Steroid eye drops (dexamethasone, prednisolone, loteprednol) have specific uses in eye inflammation, but self-medicating with them for eye flu is dangerous and never appropriate without ophthalmologist supervision. Reasons: they suppress the immune response, which can worsen viral infections (especially herpes simplex keratitis, a specific sight-threatening viral eye infection); they can raise intraocular pressure and cause steroid-induced glaucoma with sustained use; they can accelerate cataract formation; they can mask worsening infection making complications harder to detect. An ophthalmologist may prescribe short-course steroid drops for specific situations, severe allergic conjunctivitis not responding to antihistamines, immune-mediated inflammation, post-surgical inflammation, with monitoring for pressure and side effects. Never accept steroid drops from a pharmacist without an ophthalmologist's specific written prescription for your case.

The three most common types look similar but have distinguishing features. Viral eye flu (usually adenovirus, the type behind Indian monsoon outbreaks) typically starts in one eye and spreads to the other in 1-2 days, has watery clear discharge, often comes with cold or sore throat symptoms, and both eyes feel gritty and itchy. Bacterial conjunctivitis often affects one eye more than the other, produces thick yellow or green discharge that glues eyelashes shut on waking, and is typically less itchy but more painful. Allergic conjunctivitis affects both eyes symmetrically, intense itching is the dominant symptom, discharge is watery and clear, and it comes with a runny nose or sneezing, no fever or cold. When in doubt, a same-day ophthalmologist consult in your Indian city can distinguish the three within minutes and prescribe accordingly.

Three seasonal factors converge in Indian monsoon (June-September) to drive eye flu outbreaks: (a) higher ambient humidity and warmer temperatures suit adenovirus survival on surfaces and prolong its infectious period; (b) crowded indoor spaces (people avoiding rain), reduced ventilation, and shared surfaces (public transport, offices, schools) increase transmission opportunities per day; (c) rain-related environmental changes, waterlogging, humidity in homes, can increase both dust-mite allergen levels and irritant exposure. Together this creates the pattern of large simultaneous outbreaks in urban Indian schools and offices between July and September. Preventive measures for the season: strict hand hygiene, avoiding face-touching, not sharing towels or eye drops, and keeping affected household members separated from vulnerable family (elderly, immunocompromised, contact-lens wearers).

Yes, and yes. HSV keratitis is an uncommon but potentially sight-threatening form of viral eye infection. HSV-1 (same virus that causes cold sores) can spread from mouth to eye via hand contact and cause a specific pattern of corneal ulceration called dendritic keratitis. Warning signs that suggest HSV rather than routine adenoviral eye flu: severe pain out of proportion to visible redness, marked light sensitivity, one eye significantly worse than the other, decreased vision, or a visible corneal ulcer on close inspection. Any of these warrants same-day ophthalmology assessment, untreated HSV keratitis can cause corneal scarring and permanent vision loss, but treated early with antiviral drops (acyclovir or ganciclovir eye drops) prognosis is usually good. Never use steroid drops on suspected HSV, they can accelerate corneal damage.

Contact lens wearers face 3-5 times higher risk of microbial conjunctivitis than non-wearers, particularly bacterial and fungal types. Reasons: (a) lenses trap microorganisms against the corneal surface for extended periods; (b) hands regularly touching eyes during lens insertion and removal introduce pathogens; (c) improper lens hygiene (extended wear beyond recommended duration, poor case cleaning, reusing solution) allows biofilm buildup; (d) tap water contact (rinsing lenses or cases with tap water) exposes them to Acanthamoeba, a serious sight-threatening pathogen. Rules for lens wearers: never wear lenses during active eye infection (throw away the pair being worn when symptoms started); use fresh solution daily, replace case every 3 months; never top up old solution; do not swim, shower, or sleep in lenses unless specifically designed for it; see an ophthalmologist immediately for any red painful eye, routine 'eye flu' in a lens wearer needs faster escalation than in a non-wearer.

Contagious period depends on the type. Viral conjunctivitis (adenovirus, most common in Indian outbreaks) is contagious from the first symptoms until eyes are no longer visibly red and discharging, typically 5-10 days. Bacterial conjunctivitis stops being contagious 24-48 hours after starting antibiotic drops. Allergic and irritant conjunctivitis are not contagious at all. Practical rule for viral cases: stay home from work, school, and public places while eyes are red or discharging. Return when discharge has stopped and redness has clearly reduced. Return to gym, swimming, contact sports, and any activity involving shared equipment only after full resolution. For children in school, most Indian schools have policies requiring 5-7 days off; check with the school before sending back.

Stop wearing contact lenses immediately at the first sign of eye flu and do not restart until symptoms have fully resolved plus 2-3 days clear. Throw away the pair being worn when symptoms began, along with the lens case and any solution in use, do not attempt to disinfect and reuse, as microbial contamination is likely and standard cleaning cannot guarantee elimination. Wear glasses only during the illness. Once symptoms resolve, start with fresh lenses from a new sealed pack, fresh solution, and a new case. If symptoms recur or the eye still feels uncomfortable when lenses are worn again, see an ophthalmologist rather than continuing, contact-lens-associated corneal infections can escalate quickly. In India, contact lens wearers are advised to skip lenses entirely during monsoon eye flu outbreak periods and rely on glasses even without symptoms, the risk-benefit tips against lenses during outbreak seasons.

Most conjunctivitis treatments used in adult non-pregnant patients need re-evaluation during pregnancy. Safe in pregnancy: cold and warm compresses, preservative-free artificial tears, strict hand hygiene, and rest, the mainstays of viral conjunctivitis care. Antibiotic drops (chloramphenicol, moxifloxacin, ciprofloxacin, ofloxacin) are generally considered safe for short courses in pregnancy for bacterial conjunctivitis, but should be prescribed by an ophthalmologist rather than self-obtained. Antihistamine eye drops for allergic conjunctivitis (ketotifen, olopatadine) are considered relatively safe in pregnancy but check with your obstetrician before starting. Avoid entirely during pregnancy: steroid eye drops without ophthalmologist supervision (as always), and any oral medication for eye conditions without doctor consultation. Contact your ophthalmologist and share your pregnancy status before starting any prescription eye treatment.

All three hit the same underlying vulnerability: airway hyperresponsiveness (AHR). In asthmatic lungs, bronchial smooth muscle has a hair-trigger sensitivity that healthy lungs don't have. Cold air: breathing cold, dry air rapidly causes the airway lining to lose heat and moisture. This triggers mast cells to release histamine and leukotrienes — exactly the same chemicals released during an allergen response — causing bronchoconstriction within minutes. Exercise: increased breathing rate draws in more air faster, which dries and cools the airways. Post-exercise, when breathing slows, the airways experience rapid temperature/moisture swings. This is 'exercise-induced bronchoconstriction' (EIB) — affects up to 40% of asthma patients and up to 90% in cold-air sports. Viral infections (rhinovirus, RSV): viruses directly infect airway epithelium, releasing chemokines that amplify the existing Th2 inflammatory response. Even a mild cold that a non-asthmatic shrugs off can trigger an asthmatic to have a severe exacerbation needing oral steroids. This is why annual flu vaccination is so important — preventing viral infection prevents one of the biggest exacerbation triggers.

This distinction has become clinically crucial because treatment response differs significantly. Eosinophilic asthma (roughly 50–60% of moderate-severe asthma): driven by Th2 immunity — mast cells, IgE, IL-4/IL-5/IL-13 cytokines, and high blood/sputum eosinophil counts. This type responds very well to inhaled corticosteroids (ICS) and, for severe cases, to biologic therapies (mepolizumab: anti-IL-5; benralizumab: anti-IL-5 receptor; dupilumab: anti-IL-4/13 receptor). Blood eosinophil count above 300 cells/µL is a reasonable threshold for biologic trial. Non-eosinophilic (neutrophilic) asthma: driven by innate immunity, often triggered by pollution, smoking, obesity, or bacterial infection. ICS are less effective and may even increase infection risk. Macrolide antibiotics (azithromycin) have some evidence in this phenotype. Why does this matter for you as a patient? If your asthma remains poorly controlled despite high-dose ICS + LABA (a standard step-up), ask your pulmonologist about eosinophil testing and whether a biologic is indicated. In India, mepolizumab (Nucala) and omalizumab (Xolair) are available at major centres (AIIMS, PGI, Tata Memorial, Apollo) under DCGI approval, typically ₹25,000–80,000/dose depending on body weight.

Not definitely — but your risk is meaningfully elevated. Asthma heritability is around 60–70% (twin studies). The genes involved — ADAM33 (airway remodeling), IL-4 and IL-13 genes (IgE production), and over 50 loci identified in genome-wide association studies — create a susceptibility, not a destiny. What typically converts susceptibility into disease: (1) early-life allergen exposure — children who grow up with intense dust mite or pet dander exposure in genetically susceptible homes have higher rates; (2) viral lower respiratory infections before age 3 (RSV, rhinovirus) — these appear to 'prime' the immune system toward the Th2 pathway in susceptible children; (3) air pollution — both outdoor PM2.5 (Delhi, Mumbai rank among the world's most polluted cities) and indoor biomass-smoke exposure. If asthma runs in your family, the practical steps are: allergen-proof mattress covers from birth for new babies, no indoor smoking ever, flu shots every year, and watching for wheeze or recurrent 'chest colds' in children — those are worth flagging to a paediatrician early rather than waiting.

Biologics are injectable monoclonal antibodies that target specific inflammatory proteins in the asthma cascade — unlike inhalers that broadly suppress inflammation, biologics are precision medicine. The main options approved for severe asthma: (1) Omalizumab (Xolair): anti-IgE antibody — blocks IgE from binding mast cells and basophils; indicated for severe allergic asthma with high IgE levels; reduces exacerbations by 25–50%; (2) Mepolizumab (Nucala), benralizumab (Fasenra): anti-IL-5 pathway; indicated for severe eosinophilic asthma (blood eosinophils ≥300/µL); reduces severe exacerbations by 50–70%; (3) Dupilumab (Dupixent): anti-IL-4Rα — blocks both IL-4 and IL-13; also indicated for atopic dermatitis and eosinophilic esophagitis. Who qualifies: severe asthma not controlled despite high-dose ICS + LABA; typically needs confirmation of the asthma phenotype (eosinophil count, IgE levels, allergy skin-prick tests). In India, these are available at AIIMS Delhi, PGI Chandigarh, and major Apollo, Fortis, and Manipal Hospital respiratory centres. Cost is the main barrier: ₹20,000–80,000 per injection (monthly to 2-monthly dosing). Some state government programmes and Ayushman Bharat covers biologic therapy for eligible rare respiratory disease cases.

An asthma attack unfolds in three overlapping layers, usually within minutes of a trigger. (1) Bronchoconstriction: smooth muscle wrapped around the airway walls contracts suddenly — the airway tube narrows dramatically, like squeezing a garden hose. This is the fastest component (seconds to minutes) and is what a rescue inhaler (salbutamol/albuterol — a short-acting beta-2 agonist) reverses by relaxing smooth muscle. (2) Airway inflammation: the lining swells from inflammatory cells pouring in — eosinophils, mast cells, neutrophils. The airway wall thickens from the inside, further reducing the internal diameter. This takes hours to days to develop and is what inhaled corticosteroids (ICS) treat. (3) Mucus plugging: goblet cells secrete thick, viscous mucus in excess. During a bad attack, mucus can physically plug smaller airways, creating areas of complete blockage. This explains why chest tightness persists even after smooth muscle relaxes — the plug is still there. Physical sensation: patients often describe it as breathing through a wet blanket, or trying to exhale through a straw. The characteristic wheeze is the sound of air pushing through narrowed, mucus-coated airways.

Nocturnal worsening is extremely common — around 70% of asthma deaths occur at night or in the early hours of the morning. Multiple mechanisms converge at night: (1) Circadian dip in cortisol (natural anti-inflammatory hormone) — peaks in early morning, hits its nadir around 2–4 am; airway inflammation is least suppressed in this window. (2) Supine position — lying flat increases vagal tone, promotes mucus pooling in central airways, and reduces functional residual capacity (lung volume), making the airways more prone to closure. (3) GERD micro-aspiration — stomach acid is more likely to reflux in a supine position; even small amounts reaching the back of the throat can reflexively trigger bronchospasm via the vagal nerve. (4) Allergen exposure in bed — dust mites live in pillows and mattresses and peak allergen load is during sleep. If you're consistently waking between 2–4 am with wheeze, discuss with your pulmonologist: this pattern often indicates that daytime ICS alone isn't sufficient and may need a long-acting bronchodilator (LABA) or leukotriene modifier added. It's not inhaler failure — it's a specific pathophysiological pattern that often requires a step-up in the preventer regimen.

Diagnosis combines history, examination, and objective lung function testing. History: the classic pattern is episodic wheeze, cough (worse at night), chest tightness, and breathlessness triggered by identifiable factors — important because asthma's variability is itself a diagnostic clue. A single normal examination in clinic doesn't rule out asthma (airways may be fine between attacks). Spirometry: the key test. It measures FEV1 (forced expiratory volume in 1 second) and FVC (forced vital capacity). Asthma shows obstructive pattern (FEV1/FVC <0.7) that is reversible — FEV1 improves ≥12% and ≥200 mL after inhaling a bronchodilator (salbutamol 400 mcg via spacer). This reversibility differentiates asthma from COPD (fixed obstruction). Peak flow monitoring: daily home peak flow readings over 2 weeks — variability >20% between morning and evening supports asthma. Allergy testing: skin-prick test or specific IgE blood test identifies allergen triggers. Bronchial provocation test (methacholine challenge): used when spirometry is normal but clinical suspicion is high — confirms airway hyperresponsiveness. In India, spirometry is available at all medical college pulmonology departments (₹200–500), most private respiratory clinics, and major diagnostic centres (Dr Lal Path Labs, Metropolis, SRL).

Two completely different types of medication serving two different purposes. Reliever (rescue) inhaler: contains a short-acting beta-2 agonist (SABA) — salbutamol (Ventolin, Asthalin) most commonly in India. Works within 5–15 minutes by relaxing smooth muscle. This is your emergency tool — use it when you have symptoms. It doesn't treat the underlying inflammation. Using it more than twice a week means your asthma is not well-controlled. Preventer inhaler: contains an inhaled corticosteroid (ICS) — budesonide (Foracort, Budecort), fluticasone (Flixotide), beclomethasone. Reduces airway inflammation over time; must be used daily even when feeling well. Takes 2–4 weeks to reach full effect. Many patients make the mistake of stopping the preventer when they feel better — this allows inflammation to build back up, leading to the next attack. Some inhalers are combination devices (ICS + LABA in one inhaler — e.g., salmeterol/fluticasone = Seretide/Foracort). These are preventer + controller in one, but you still need a separate salbutamol rescue inhaler for acute symptoms. The GINA 2023 guidelines recommend against using reliever-only therapy for anyone with persistent asthma — even mild persistent asthma needs a daily ICS preventer to reduce exacerbation risk.

Yes — if your child has confirmed CF, both of you must be CFTR mutation carriers. CF follows strict autosomal recessive inheritance: the child needs one defective CFTR gene from each parent. Neither of you would have CF yourselves (carriers have one normal gene that compensates), and most carriers are completely healthy with no symptoms. Here's the probability breakdown if both parents are carriers: 25% chance each pregnancy produces a child with CF (two defective copies); 50% chance of a carrier child (one defective copy — healthy like you); 25% chance of a non-carrier child. For future pregnancies, prenatal genetic testing is available: chorionic villus sampling (CVS) at 10–12 weeks or amniocentesis at 15–20 weeks can test the fetus for CFTR mutations. In India, CF genetic testing (CFTR mutation panel) is available at specialized genetics labs — Medgenome, MedScan (Hyderabad), and academic centres like PGIMER Chandigarh have CF genetics expertise. Cost is approximately ₹5,000–15,000 depending on the panel size. If you're planning another pregnancy, a genetic counsellor can walk through your specific mutations and reproductive options.

The sweat test (pilocarpine iontophoresis) is the gold standard for CF diagnosis. In CF, the defective CFTR protein cannot properly regulate chloride channels in sweat gland cells — so sweat contains abnormally high chloride levels. The test: a small electric current stimulates sweat production at the wrist or forearm; sweat is collected on gauze for 30 minutes; chloride level is measured. Results: normal <30 mmol/L; borderline 30–59 mmol/L; positive for CF ≥60 mmol/L. Accuracy is high — sensitivity and specificity both above 95% when properly performed. Where it fits in the diagnostic pathway: Newborn screening in India (where available) detects elevated blood immunoreactive trypsinogen (IRT) — a flag, not a diagnosis. Sweat test then confirms. Genetic testing identifies the specific CFTR mutations, which matters for treatment (some CFTR modulators only work on specific mutation classes). In India, newborn screening is available in many private hospitals and some state government programmes (Tamil Nadu, Maharashtra have expanded screening). Sweat testing is available at paediatric tertiary centres — AIIMS Delhi, Manipal, Christian Medical College Vellore, Rainbow Hospital Hyderabad. CF is underdiagnosed in India — many children are diagnosed years after symptom onset because TB or recurrent pneumonia is initially suspected instead.

Yes, dramatically — they represent the first treatments that address the underlying CFTR protein defect rather than managing consequences. How they work: the CFTR protein is a chloride channel. Modulators are small molecules that correct the defective protein. Different mutation classes need different approaches: 'Potentiators' (ivacaftor/Kalydeco) open CFTR channels that are at the cell surface but not functioning — works best for gating mutations like G551D. 'Correctors' (lumacaftor, tezacaftor) help misfolded ΔF508 protein reach the cell surface. Triple combination therapy (elexacaftor/tezacaftor/ivacaftor — Trikafta/Kaftrio) addresses ΔF508 (70% of CF patients) and achieved what was once thought impossible: FEV1 improvements of 14 percentage points, 63% reduction in exacerbations, and — most remarkably — normalisation of sweat chloride in some patients. Life expectancy for children born with CF today, who have access to modulators, is projected to exceed 70 years. In India: Trikafta is not yet CDSCO-approved as of 2025, but patients have accessed it via compassionate use programmes and import. Cost is approximately USD 300,000/year in the US (Vertex Pharmaceuticals offers a managed access programme for low-income countries). Advocate through the Indian CF Foundation (CFFI) for access.

CF management is genuinely intensive — it's a condition where daily adherence makes an enormous difference to long-term lung function. The typical daily routine for a CF patient includes: (1) Airway clearance therapy: 20–30 minutes twice daily using chest physiotherapy, active cycle of breathing techniques (ACBT), or a high-frequency chest oscillation vest (Vest therapy device). Airway clearance loosens and moves mucus from the airways before it causes obstruction or infection. This is non-negotiable — skipping it accelerates lung decline. (2) Nebulised medications: in order — hypertonic saline (loosens mucus), then dornase alfa/Pulmozyme if prescribed (breaks down mucus DNA), then bronchodilator, then inhaled antibiotic (tobramycin, aztreonam in alternating months if chronically colonised with Pseudomonas). (3) Pancreatic enzyme replacement (PERT): capsules with every meal and snack. CF mucus blocks pancreatic ducts, preventing enzyme release — without PERT, fat and protein aren't absorbed, causing malnutrition. (4) High-calorie diet: CF patients need 120–150% of normal caloric intake because energy is consumed by the increased work of breathing and chronic infections. Dietitian input is essential. (5) Monitoring: regular sputum cultures (quarterly), lung function (6-monthly), liver ultrasound (annual), blood glucose (CF-related diabetes develops in 30–50% of CF patients by adulthood). CF centres (multidisciplinary teams with pulmonologist, physiotherapist, dietitian, CF nurse, and genetic counsellor) consistently achieve better outcomes than general paediatric care — seek CF centre registration where possible.

Stepping up means adding or strengthening preventive medication when the current regimen isn't controlling asthma adequately. The GINA step-up framework: Step 1 (mild intermittent): salbutamol (SABA) as needed only — symptoms less than twice a week, no nighttime waking. Step 2 (mild persistent): add a low-dose inhaled corticosteroid (ICS) daily — symptoms more than twice a week. Alternative: montelukast (leukotriene modifier), especially useful in allergic asthma and children who won't use inhalers well. Step 3 (moderate persistent): increase ICS to medium-dose, OR add a long-acting bronchodilator (LABA) to low-dose ICS — often given as a single combination inhaler (salmeterol+fluticasone = Seretide; formoterol+budesonide = Foracort). Step 4 (severe persistent): high-dose ICS + LABA + consider add-on (tiotropium, leukotriene modifier, or oral steroid short courses). Step 5: referral for biologic therapy (mepolizumab, omalizumab). The trigger for stepping up: using a rescue inhaler more than twice a week, any nighttime symptoms, activity limitation, or a significant exacerbation requiring oral steroids or hospital care. Stepping down: after 3 months of good control at a step, carefully step down to the lowest effective dose to minimise side effects.

Montelukast (Singulair, and generic Montair in India) is a leukotriene receptor antagonist — it blocks leukotriene D4, one of the key inflammatory chemicals that cause airway swelling and mucus production in asthma. In India it's widely available — approximately ₹3–6 per tablet as generic Montair. Where it works best: (1) Allergic/atopic asthma — particularly patients who also have allergic rhinitis (hay fever); montelukast addresses both conditions with one tablet. A morning tablet controls allergic rhinitis symptoms during the day. (2) Exercise-induced bronchoconstriction — it reduces exercise-triggered wheeze in 50–70% of patients when taken daily. (3) Children who cannot reliably use inhalers — oral tablet is easier to administer for young children (available as a 4 mg chewable tablet for ages 2–5). Where it's less useful: non-allergic asthma, COPD, severe persistent asthma where ICS + LABA gives more powerful control. Side effect note: in 2020, the FDA added a black box warning for neuropsychiatric side effects (mood changes, sleep disturbances, suicidal ideation in rare cases) — mainly affecting children and adolescents. Discuss with your paediatrician if a child on montelukast shows mood or behaviour changes.

Asthma in patients over 65 is frequently underdiagnosed and undertreated for several reasons. First, older patients often attribute breathlessness to 'getting older' rather than identifying it as treatable asthma. Second, the classic wheeze may be less pronounced — atypical presentations include chronic dry cough, reduced exercise tolerance, or frequent respiratory infections rather than classic attacks. Third, comorbidities (heart failure, COPD, OSA) create diagnostic confusion — all can cause breathlessness; spirometry with bronchodilator reversibility test is essential to distinguish. Practical differences in elderly asthma management: (1) Inhaler dexterity and cognition — arthritic hands or cognitive decline can impair inhaler technique even more than in younger patients; breath-actuated inhalers (Autohaler) or nebulisers may be better options; (2) Drug interactions — many elderly patients take beta-blockers for heart conditions; non-selective beta-blockers (propranolol) worsen asthma; cardioselective beta-blockers (bisoprolol, metoprolol) are safer but should still be discussed with the pulmonologist; (3) Oral corticosteroid risks — elderly patients on frequent short courses face significantly higher fracture, diabetes, and hypertension risk; minimise through optimised preventive inhaler regimen; (4) Monitoring: use a peak flow diary plus fall risk assessment (breathlessness increases fall risk from hypoxia-related dizziness).

Frequency depends on control level, but here's the practical framework: Newly diagnosed or uncontrolled asthma: monthly until control is achieved. Controlled asthma on medication: every 3–6 months once stable. Patients on high-dose ICS or biologics: every 3 months (side effect monitoring and stepping-down opportunity). Post-exacerbation: within 2 weeks of any oral steroid course or hospital visit — this is when most recurrences happen and when the care plan usually needs updating. What each visit should cover: (1) Control assessment: symptom frequency, nighttime waking, rescue inhaler use (calculate puffs per week from a 200-dose inhaler); (2) Inhaler technique demonstration — reassess every visit, not just the first; (3) Peak flow diary review if the patient is monitoring at home; (4) Adherence barriers: cost, side effect concerns, forgetfulness patterns; (5) Trigger review: any new exposures (new pet, job change, house renovation); (6) Spirometry: at least annually in stable patients, 3-monthly in moderate-to-severe asthma. In India, asthma follow-up at government hospitals is available free or at very low cost — AIIMS OPD, ESI hospitals, municipal corporation health centres. Most patients do better with a dedicated pulmonologist rather than general practitioner follow-up once they're on Step 3 therapy or above.

Prioritise by evidence. The highest-yield changes: (1) Dust mite reduction — allergen-proof covers for mattress, pillow, and duvet (₹500–1,500); wash bedding weekly at 60°C; remove carpets from bedroom if feasible. Dust mites are the most common asthma trigger in India across all age groups. (2) Remove or reduce pet dander exposure — if allergic, keep pets outside the bedroom; wash hands after handling; HEPA air purifier (₹4,000–15,000) reduces airborne dander by 60–80%. (3) Eliminate indoor smoking completely — even 'smoking on the balcony' leaves residue on clothes that re-enters the room. Secondhand smoke is a major trigger for childhood asthma. (4) Cockroach allergen management — seal food containers, fix leaking taps, use bait traps rather than sprays (aerosols themselves trigger asthma); professional pest control if infestation is heavy. (5) Reduce damp and mould — fix water leaks, use exhaust fans in bathrooms, avoid drying clothes indoors. Mould spores are a significant trigger particularly in monsoon months. On AQI-alert days (available on the Safar India app for major cities), keep windows closed and use an air purifier if available.

The most effective asthma action plans use a traffic-light (green/yellow/red) system tied to symptoms or peak flow readings. Green zone (peak flow 80–100% of personal best): continue regular medications, no limitations on activity. Yellow zone (peak flow 50–79%): asthma is getting worse. Start oral prednisolone if prescribed, increase rescue inhaler to 4–8 puffs every 20 minutes for 3 doses, call doctor within 24 hours. Red zone (peak flow <50%): medical emergency. Use rescue inhaler immediately, take oral prednisolone if available, go to hospital or call 108 ambulance if no improvement after 15 minutes. The plan must include: patient's personal best peak flow (measured when stable), list of identified triggers, emergency contact number, nearest hospital or emergency department. In India, GINA's free action plan template in Hindi and other regional languages is available from your pulmonologist or download from ginaasthma.org. The plan should be written down, not just discussed — discharge recall of verbal-only instructions is less than 30%.

This is one of the most impactful nursing interventions in asthma — studies show >60% of patients use MDIs incorrectly, making their medication largely ineffective. The teach-back method is the gold standard: nurse demonstrates, patient demonstrates back, nurse corrects. For a metered-dose inhaler (MDI): (1) shake well before use; (2) exhale fully away from inhaler; (3) seal lips around mouthpiece; (4) press canister and begin slow deep inhale simultaneously (the single most common error is pressing first then inhaling, which delivers only 10% to the lungs); (5) hold breath 10 seconds; (6) wait 30–60 seconds before second puff. Always recommend a spacer (₹150–400 at pharmacies) — spacers increase drug deposition in the lungs by 40–50% and are particularly important for children and elderly patients. For dry-powder inhalers (Rotacap, Rotahaler), inhale forcefully — different from MDI. Verify at every follow-up visit. A patient who has been on the same inhaler for years may have developed bad habits they're unaware of.

The assessment has three layers. (1) History: how often does the patient wheeze or cough? Does it wake them at night? How frequently are they using their rescue inhaler (salbutamol)? Using a rescue inhaler more than twice a week signals poorly controlled asthma. What are their known triggers — dust mites, pollen, pet dander, exercise, cold air, viral infections, smoke? (2) Physical exam: listen for wheeze (polyphonic = diffuse bronchospasm; monophonic = partial obstruction like foreign body) and use of accessory muscles. Check SpO2 — below 92% indicates severe exacerbation requiring immediate escalation. (3) Lung function: spirometry confirms diagnosis (FEV1/FVC <0.7 post-bronchodilator with >12% reversibility confirms asthma). Peak flow measurement tracks day-to-day variability — a drop of >20% below personal best is an early warning sign. Allergy skin-prick testing or IgE panel identifies specific triggers. In India, affordable spirometry is available at government medical college respiratory departments (₹200–500) and private pulmonology clinics.

No — asthma is not contagious. You cannot catch it from someone who is wheezing or coughing. Asthma is a chronic non-communicable disease (NCD) caused by a combination of genetic predisposition and environmental factors — not by a virus, bacteria, or any infectious agent. What can happen is that a respiratory infection like the flu or cold can trigger an asthma attack in someone who already has the condition. The infection spreads; the asthma does not. India has one of the highest asthma burdens globally — around 34 million people — mostly driven by air pollution, indoor allergens (dust mites, cockroach dander), and genetic susceptibility, not person-to-person transmission.

It depends on when it starts. Childhood asthma often improves with age — roughly 50% of children appear symptom-free by their late teens as airways grow larger. But 'outgrowing' it doesn't always mean it's gone: around half of those who go quiet in adolescence see symptoms return in their 30s or 40s, often triggered by a respiratory illness, pregnancy, or a new occupational exposure. Adult-onset asthma (first diagnosed after 20) is less likely to resolve on its own and typically requires long-term controller medication. The key point: asthma should be actively managed throughout — avoiding triggers, using inhaled corticosteroids as prescribed, and having an action plan — not left alone in the hope it disappears.

Yes, significantly. Respiratory viruses — influenza, RSV, rhinovirus (common cold) — are the single most common trigger for severe asthma attacks, especially in children. The virus inflames already-sensitive airways, causing them to narrow more severely than usual. This is why people with asthma should get the annual flu shot: studies consistently show it reduces the risk of asthma hospitalisation by 30–40% during peak flu season. In India, the flu vaccine costs ₹500–1,200 at most pharmacies and private clinics and is recommended by the Indian Academy of Pediatrics for asthmatic children from 6 months of age. COVID-19 vaccination is also recommended — both significantly reduce severity of respiratory complications in people with asthma.

Not necessarily, but your risk is meaningfully higher. Having a parent with asthma roughly doubles your likelihood of developing it compared to the general population. What actually tips someone into asthma is usually an environmental exposure layered on top of that genetic susceptibility — early childhood respiratory infections, prolonged exposure to tobacco smoke, living near heavy traffic, or growing up in a damp, dusty home. The genetic component sets the sensitivity; the environment pulls the trigger. If asthma runs in your family, reducing indoor allergen load (mattress covers, HEPA filters), avoiding passive smoke, and watching for early wheeze in children are the highest-yield preventive steps.